MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

Search

Bruker Corp

Atidarymo kaina

SektoriusSveikatos priežiūra

36.51 4.76

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

34.39

Max

36.61

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-13M

4.2M

Pardavimai

-4M

797M

P/E

Sektoriaus vid.

59.385

35.739

Dividendų pajamingumas

0.64

Pelno marža

0.527

Darbuotojai

11,396

EBITDA

-21M

68M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+28.34% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

0.64%

3.08%

Kitas uždarbis

2025-11-04

Kitas dividendų mokėjimo data

2025-10-03

Kita Ex Dividend data

2025-12-01

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-551M

4.7B

Ankstesnė atidarymo kaina

31.75

Ankstesnė uždarymo kaina

36.51

Naujienos nuotaikos

By Acuity

9%

91%

7 / 371 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bullish Evidence

Bruker Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-09-02 22:10; UTC

Pagrindinės rinkos jėgos

Bruker Shares Fall on Convertible Share Offering Aimed at Debt Repayment

Akcijų palyginimas

Kainos pokytis

Bruker Corp Prognozė

Kainos tikslas

By TipRanks

28.34% į viršų

12 mėnesių prognozė

Vidutinis 44.56 USD  28.34%

Aukščiausias 60 USD

Žemiausias 38 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Bruker Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

10 ratings

6

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.97 / 40.73Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bullish Evidence

Vidutinės trukmės periodas

Bullish Evidence

Ilgalaikis periodas

Bearish Evidence

Rinkos nuotaikos

By Acuity

7 / 371 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Bruker Corp

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. It offers life science tools, and single and multiple modality systems; life science mass spectrometry; MALDI Biotyper rapid pathogen identification platform and related test kits, DNA test strips, and fluorescence-based polymerase chain reaction technology; genotype and fluorotype molecular diagnostics kits; research, analytical, and process analysis instruments and solutions; SARS-CoV 2 testing for the diagnosis of COVID-19 infection; and Fluorotyper-SARS-CoV 2 plus kits. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; products and services to support the multi-omics needs of researchers in translational research, drug, and biomarker discovery; superconducting materials, such as metallic low temperature superconductors; devices and complex tools based on metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. The company was incorporated in 1991 and is headquartered in Billerica, Massachusetts.
help-icon Live chat